IP Library Assignment 039767/0695
Patent Assignment
Reel/Frame 039767/0695

Assignment of Assignor's Interest

Recorded: 2016-09-16 Pages: 11
Assignor
MERCK SHARP & DOHME CORP.
Executed: 2016-09-06
Assignee
ARALEZ PHARMACEUTICALS TRADING DAC
56 FITZWILLIAM SQUARE, DUBLIN 2, IRELAND
Covered Properties (21)
Nor-Seco Himbacine Derivatives Useful as Thrombin Receptor Antagonists
Patent: 6,645,987 →
Application: 09/880,222 →
Publication: US 2002/0026050
Thrombin Receptor Antagonists
Patent: 7,304,078 →
Application: 10/412,982 →
Publication: US 2003/0216437
Thrombin Receptor Antagonists
Patent: 6,894,065 →
Application: 10/457,256 →
Publication: US 2004/0006105
Thrombin Receptor Antagonists
Patent: 7,488,742 →
Application: 10/671,216 →
Publication: US 2004/0152736
Crystalline Polymorph of a Bisulfate Salt of a Thrombin Receptor Antagonist
Patent: 7,235,567 →
Application: 10/755,066 →
Publication: US 2004/0176418
Exo-Selective Synthesis of Himbacine Analogs
Patent: 7,772,276 →
Application: 11/330,521 →
Publication: US 2006/0217422
Synthesis of Himbacine Analogs
Patent: 7,541,471 →
Application: 11/330,935 →
Publication: US 2006/0173189
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Patent: 7,605,275 →
Application: 11/331,324 →
Publication: US 2006/0247450
Thrombin Receptor Antagonists
Patent: 7,713,999 →
Application: 11/733,635 →
Publication: US 2007/0179187
Immediate-Release Tablet Formulations of a Thrombin Receptor Antagonist
Application: 11/771,520 →
Publication: US 2008/0031943
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Patent: 7,687,631 →
Application: 11/824,245 →
Publication: US 2008/0004449
Synthesis of Himbacine Analogs
Patent: 7,626,045 →
Application: 12/428,773 →
Publication: US 2009/0203925
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Patent: 7,989,653 →
Application: 12/505,079 →
Publication: US 2009/0281321
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Patent: 8,329,905 →
Application: 12/701,174 →
Publication: US 2010/0137597
Exo-Selective Synthesis of Himbacine Analogs
Patent: 8,138,180 →
Application: 12/827,000 →
Publication: US 2010/0267947
Exo- and Diastereo- Selective Synthesis of Himbacine Analogs
Patent: 8,258,319 →
Application: 13/168,029 →
Publication: US 2011/0251392
Exo-Selective Synthesis of Himbacine Analogs
Patent: 8,273,790 →
Application: 13/370,768 →
Publication: US 2012/0142914
Active Metabolite of a Thrombin Receptor Antagonist
Patent: 8,575,351 →
Application: 13/376,093 →
Publication: US 2012/0214845
Exo- and Diastereo- Selective Synthesis of Himbacine Analogs
Patent: 8,618,314 →
Application: 13/563,136 →
Publication: US 2012/0296093
Co-Crystal of the Par-1 Receptor Antagonists Vorapaxar and Asprin
Patent: 9,604,971 →
Application: 14/905,193 →
Publication: US 2016/0159779
Immediate-Release Tablet Formulations of a Thrombin Receptor Antagonist
Application: 15/066,726 →
Publication: US 2016/0193196
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
Change of Name Mar 11, 2013
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 029959/0019 →
Security Interest Sep 29, 2016
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 039892/0309 →
Security Interest Aug 24, 2018
From: ARALEZ PHARMACEUTICAL TRADING DAC
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046696/0772 →
Corrective Assignment to Correct the Conveying Party Previously Recorded at Reel: 046696 Frame: 0772. Assignor(S) Hereby Confirms the Assignment. Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
Receiving Party/Assignee Address Change for Assignment Recorded at Reel/Frame 039767/0695 Aug 31, 2018
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 046989/0669 →
Assignment of Assignor's Interest Sep 10, 2020
From: TOPROL ACQUISITION LLC
To: XSPIRE PHARMA, LLC
Reel/Frame 053731/0376 →
Assignment of Assignor's Interest Oct 12, 2020
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: TOPROL ACQUISITION LLC
Reel/Frame 054027/0047 →